Literature DB >> 6107410

Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis.

R J Dickinson, M F Dixon, A T Axon.   

Abstract

The role of colonoscopy in the surveillance of patients with ulcerative colitis for dysplasia was investigated in 43 patients with longstanding disease extending proximally beyond the splenic flexure. The examination was well tolerated and no complications were recorded. Dysplasia was found in 9 patients in one or more biopsies and was severe in 2, moderate in 1, and mild in 6. Both the patients with severe dysplasia had a carcinoma at subsequent operation. Colonoscopy may allow complete examination of the colon and biopsy of suspicious lesions and, since dysplasia may spare the rectum, colonoscopy with biopsy is a desirable component of any surveillance programme of the at-risk colitic.

Entities:  

Mesh:

Year:  1980        PMID: 6107410     DOI: 10.1016/s0140-6736(80)90286-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease?

Authors:  S A Dundas; R Kay; S Beck; D W Cotton; A J Coup; D N Slater; J C Underwood
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

Review 3.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

4.  Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease.

Authors:  A P Manning; O R Bulgim; M F Dixon; A T Axon
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

5.  Large bowel mucosal dysplasia and carcinoma in ulcerative colitis.

Authors:  D C Allen; J D Biggart; P C Pyper
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

6.  Surveillance in ulcerative colitis: burdens and benefit.

Authors:  H W Jones; J Grogono; A M Hoare
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

7.  Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.

Authors:  B A Lashner; M D Silverstein; S B Hanauer
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.